A key genetic factor for fucosyllactose utilization affects infant gut microbiota development
about
The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.Biome engineering-2020.Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohenseMicroscale spatial analysis provides evidence for adhesive monopolization of dietary nutrients by specific intestinal bacteria.Bifidobacterium breve UCC2003 metabolises the human milk oligosaccharides lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways.Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section.Trophic Interactions of Infant Bifidobacteria and Eubacterium hallii during L-Fucose and Fucosyllactose Degradation.The Fecal Microbial Community of Breast-fed Infants from Armenia and Georgia.Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pregnant Women but Not in Their Neonates Aged One Month.Fecal Short-Chain Fatty Acid Variations by Breastfeeding Status in Infants at 4 Months: Differences in Relative versus Absolute Concentrations.Evolution of gut Bifidobacterium population in healthy Japanese infants over the first three years of life: a quantitative assessment.Unveiling bifidobacterial biogeography across the mammalian branch of the tree of life.Ontogenesis of the Gut Microbiota Composition in Healthy, Full-Term, Vaginally Born and Breast-Fed Infants over the First 3 Years of Life: A Quantitative Bird's-Eye ViewThe first crystal structure of a family 129 glycoside hydrolase from a probiotic bacterium reveals critical residues and metal cofactors.Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.Signatures in the gut microbiota of Japanese infants who developed food allergies in early childhood.Characterization and Exploitation of CRISPR Loci in Bifidobacterium longum.Prebiotics Mediate Microbial Interactions in a Consortium of the Infant Gut Microbiome.Omics of bifidobacteria: research and insights into their health-promoting activities.Bifidobacteria and the infant gut: an example of co-evolution and natural selection.Modulation of Type 1 Diabetes Risk by the Intestinal Microbiome.Identification and characterization of a sulfoglycosidase from Bifidobacterium bifidum implicated in mucin glycan utilization.Gene-trait matching across the Bifidobacterium longum pan-genome reveals considerable diversity in carbohydrate catabolism among human infant strains.Application study of 1,2-α-l-fucosynthase: introduction of Fucα1-2Gal disaccharide structures on N-glycan, ganglioside, and xyloglucan oligosaccharide.Elevated Fecal pH Indicates a Profound Change in the Breastfed Infant Gut Microbiome Due to Reduction of Bifidobacterium over the Past Century.Milk Glycans and Their Interaction with the Infant-Gut Microbiota.Influence of Intestinal Indigenous Microbiota on Intrafamilial Infection by Helicobacter pylori in Japan.Postnatal colonization with human "infant-type" Bifidobacterium species alters behavior of adult gnotobiotic mice.How Can We Define "Optimal Microbiota?": A Comparative Review of Structure and Functions of Microbiota of Animals, Fish, and Plants in AgricultureHuman Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant FormulaSharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum
P2860
Q34553267-45EB17C9-8AE0-4189-8828-20E05A47DE76Q36089258-7E214137-464F-4E37-BC1C-4290B682A803Q36174644-04B2718F-6EFF-442B-BBCF-FE3FDD039DD2Q36342238-6258CAAC-CD14-472C-A570-7A6BB4B38543Q37483852-9BD82026-81B0-4D43-8E1B-A40EB93B15E8Q37504499-3A24B03B-6993-4234-AABF-FD2C96E65698Q37611773-EDB19DD9-70F7-4A38-A12B-C09E6DF46BD4Q37620525-B21D0042-B531-453C-B4AE-C724BBDEFE3BQ37729618-4929119E-31B4-4342-A6D7-552CB0E9DC42Q37743096-D2E580A8-661F-49DB-8F8A-4A2DE1002D38Q38601534-8D003DD2-CC34-476D-8347-A3F37AD366F0Q38610353-2A2240EB-0D5B-4E1C-8F24-587B51B83015Q38635915-A8468090-3EE7-4735-AA5C-2DD6C81F6BC0Q38762828-F3CB09AF-68D8-495F-B546-A9347911C277Q39370710-5AC07908-12BC-4C31-AB40-FC6A181F936AQ40043108-69B1E3B4-783C-4F52-92D2-AA9140196089Q42369902-7BE5BFA8-7254-4228-8C9B-C0FFAF465141Q43220250-A96A4A4D-4365-4B33-B93D-A0E5B63E4E6EQ46246557-733D4644-C364-4E51-9BF2-793ADF45E121Q46293341-44073DF5-3E2B-420C-AB16-38FD239A8A1DQ46301789-8D75D2C8-C96F-47A8-AD80-1A86FF5EC6FEQ47945088-E87EE74E-5E17-4CEC-9A3C-5B57648A1EFFQ49423566-2B9EFCFB-53A2-4493-92D2-C086393A547BQ51102817-7B0CC170-9FBE-4853-9FE5-FD5F612A198EQ51736799-911AEBFF-A80E-4425-B0A4-E3FA3C4C7355Q52341406-304C5F7B-E33F-42D4-A4CD-F81D687AD78DQ54260267-A39EF9DA-59D4-496B-A808-549CEE9A3A2CQ55053255-6E2B6440-6628-41DE-A1DB-EC8A9E052CA3Q58586803-7F2ADB29-4F4C-432C-9C11-99FE0D26FC95Q58704006-3544EB3A-AB6D-4EBD-9447-F8FF7112A376Q58726466-B45EFE27-D3EC-4308-BCAF-FA71832224BE
P2860
A key genetic factor for fucosyllactose utilization affects infant gut microbiota development
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A key genetic factor for fucos ...... ant gut microbiota development
@en
A key genetic factor for fucos ...... nt gut microbiota development.
@nl
type
label
A key genetic factor for fucos ...... ant gut microbiota development
@en
A key genetic factor for fucos ...... nt gut microbiota development.
@nl
prefLabel
A key genetic factor for fucos ...... ant gut microbiota development
@en
A key genetic factor for fucos ...... nt gut microbiota development.
@nl
P2093
P2860
P50
P356
P1476
A key genetic factor for fucos ...... ant gut microbiota development
@en
P2093
Eishin Ogawa
Hiroko Kodama
Hoshitaka Matsumoto
Kana Yahagi
Kazuya Yamamoto
Satoshi Matsumoto
Saya Tajima
Taeko Hara
Takuji Yamada
P2860
P2888
P356
10.1038/NCOMMS11939
P407
P577
2016-06-24T00:00:00Z